Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General news updates Congo’s Goma airport falls! Capital protests ignite global concern The Democratic Republic of the Congo (DRC) is grappling with escalating violence as the M23 rebel group captures… byPallavi MadhirajuJanuary 28, 2025